ArticleAmerican journal of cancer research2021

THZ1, a covalent CDK7 inhibitor, enhances gemcitabine-induced cytotoxicity via suppression of Bcl-2 in urothelial carcinoma.

Kuan-Lin Kuo et al.PubMed ↗Full text ↗

No numbers read from the abstract.